Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
DOI: 10.1046/J.0306-5251.2001.01499.X
关键词:
摘要: … of some proton pump inhibitors may be greater in PMs than EMs at low doses of these drugs… PMs exposed to warfarin. Phenytoin has been reported to cause severe toxicity in PMs. New …
sci-hub.se 参考文章(63)
K Sogawa, O Gotoh, K Kawajiri, T Harada, Y Fujii-Kuriyama, Complete nucleotide sequence of a methylcholanthrene-inducible cytochrome P-450 (P-450d) gene in the rat. Journal of Biological Chemistry. ,vol. 260, pp. 5026- 5032 ,(1985) , 10.1016/S0021-9258(18)89174-8
X QIN, H XIE, W WANG, N HE, S HUANG, Z XU, D OUYANG, Y WANG, H ZHOU, Effect of the gene dosage of CYP2C19 on diazepam metabolism in Chinese subjects Clinical Pharmacology & Therapeutics. ,vol. 66, pp. 642- 646 ,(1999) , 10.1053/CP.1999.V66.103379001
Coller, Somogyi, Bochner, Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms. British Journal of Clinical Pharmacology. ,vol. 48, pp. 158- 167 ,(1999) , 10.1046/J.1365-2125.1999.00005.X
S.M. de Morais, G.R. Wilkinson, J. Blaisdell, K. Nakamura, U.A. Meyer, J.A. Goldstein, The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. Journal of Biological Chemistry. ,vol. 269, pp. 15419- 15422 ,(1994) , 10.1016/S0021-9258(17)40694-6
Christine Bouchardy, Simone Benhamou, Joyce A. Goldstein, Joyce Blaisdell, Urs Meyer, Pierre Dayer, Burhan I. Ghanayem, Gordon C. Ibeanu, Identification of New Human CYP2C19 Alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian Poor Metabolizer of Mephenytoin Journal of Pharmacology and Experimental Therapeutics. ,vol. 286, pp. 1490- 1495 ,(1998)
James Grogan, Atiqur Rahman, Frank J. Gonzalez, James W. Harris, Kenneth R. Korzekwa, Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8. Cancer Research. ,vol. 54, pp. 5543- 5546 ,(1994)
Joyce A. Goldstein, Zhou-Sheng Xiao, Joyce Blaisdell, Nan He, Song-Ling Huang, Hong-Guang Xie, Wei Wang, Chang-Hong Jiang, Feng-Xiang Yan, Zhen-Hua Xu, Hong-Hao Zhou, Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele. Journal of Pharmacology and Experimental Therapeutics. ,vol. 281, pp. 604- 609 ,(1997)
Laurent Becquemont, Philippe Beaune, Patrice Jaillon, Anne Leneveu, Christian Funck-Brentano, Annie Roux, Inhibition by omeprazole of proguanil metabolism: mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments. Journal of Pharmacology and Experimental Therapeutics. ,vol. 280, pp. 730- 738 ,(1997)
C. Bouchardy, S. Benhamou, J. A. Goldstein, J. Blaisdell, J. M. Wright, T. C. Sarich, P. Dayer, G. R. Wilkinson, G. Ibeanu, S. M. F. De Morais, R. J. Ferguson, A New Genetic Defect in Human CYP2C19: Mutation of the Initiation Codon Is Responsible for Poor Metabolism of S-Mephenytoin Journal of Pharmacology and Experimental Therapeutics. ,vol. 284, pp. 356- 361 ,(1998)
Tommy Andersson, Carl-Gunnar Reg??rdh, Ya-Ching Lou, Yuan Zhang, Marja-Liisa Dahl, Leif Bertilsson, Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects. Pharmacogenetics. ,vol. 2, pp. 25- 31 ,(1992) , 10.1097/00008571-199202000-00005